Chen FD - Search Results

1

Evaluating the efficacy and safety of oral triple sequential combination therapy for treating patients with pulmonary arterial hypertension: A multicenter retrospective study.

Zhao QH, Chen J, Chen FD, Ruan HY, Zhang W, Zhou YL, Wang QQ, Xu XL, Feng KF, Guo JZ, Gong SG, Zhang RF, Wang L. Zhao QH, et al. Among authors: chen fd. Pulm Circ. 2024 Mar 10;14(1):e12351. doi: 10.1002/pul2.12351. eCollection 2024 Jan. Pulm Circ. 2024. PMID: 38468630 Free PMC article.

2

Impact of different sequential triple oral combination therapies based selexipag on outcomes in pulmonary arterial hypertension.

Hu X, Yuan P, Chen J, Wang S, Zhao H, Wei Y, Fu J, Chen F, Ruan H, Zhang W, Zhou Y, Wang Q, Xu X, Feng K, Guo J, Gong S, Zhang R, Zhao Q, Wang L. Hu X, et al. Clin Cardiol. 2024 Feb;47(2):e24245. doi: 10.1002/clc.24245. Clin Cardiol. 2024. PMID: 38402556 Free PMC article.

3

A Study of the Efficacy and Safety of Aerobic Exercise Training in Pulmonary Arterial Hypertension (the Saturday Study): Protocol for a Prospective, Randomized, and Controlled Trial.

Jiang R, Wang L, Yuan P, Zhao QH, Gong SG, He J, Qiu HL, Luo CJ, Zhang R, Shen T, Zhan MY, Jiang YM, Chen FD, Liu JM, Shen YQ. Jiang R, et al. Among authors: chen fd. Front Med (Lausanne). 2022 Apr 5;9:835272. doi: 10.3389/fmed.2022.835272. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35449803 Free PMC article.

4

[Clinical characteristics and survival of patients with pulmonary veno-occlusive disease].

Jiang X, Chen FD, He J, Jiang R, Di RM, Zhao QH, Jing ZC. Jiang X, et al. Among authors: chen fd. Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Oct;39(10):896-900. Zhonghua Xin Xue Guan Bing Za Zhi. 2011. PMID: 22321271 Chinese.

5

Serum high-density lipoprotein cholesterol levels as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.

Zhao QH, Peng FH, Wei H, He J, Chen FD, Di RM, Jiang X, Jiang R, Chen YJ, Heresi GA, Jing ZC. Zhao QH, et al. Among authors: chen yj, chen fd. Am J Cardiol. 2012 Aug 1;110(3):433-9. doi: 10.1016/j.amjcard.2012.03.042. Epub 2012 May 4. Am J Cardiol. 2012. PMID: 22560769

6

[Efficacy and safety of ambrisentan therapy in Chinese patients with pulmonary hypertension].

Chen FD, Zhou DX, Di RM, Zou Y, Wei W, Liu XB. Chen FD, et al. Zhonghua Yi Xue Za Zhi. 2013 Sep 10;93(34):2736-8. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24360110 Clinical Trial. Chinese.

7

Atorvastatin prevents dehydromonocrotaline-induced pulmonary hypertension in beagles.

Chen D, Zhou D, Qian J, Chen F, Guan L, Dong L, Ge J. Chen D, et al. Exp Lung Res. 2012 Sep;38(7):333-43. doi: 10.3109/01902148.2012.702852. Exp Lung Res. 2012. PMID: 22888849 Free article.

8

Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention.

Yu Y, Xu J, Wang L, Ye Z, Chen Z, Chen F. Yu Y, et al. BMC Cardiovasc Disord. 2022 Oct 3;22(1):433. doi: 10.1186/s12872-022-02865-6. BMC Cardiovasc Disord. 2022. PMID: 36192682 Free PMC article.

9

Percutaneous Left Atrial Appendage Closure With a Novel LAA Occluder for Stroke Prevention in Atrial Fibrillation.

Zhang X, Hou S, Liu W, Chen W, Chen F, Ma W, Wang J, Fan Y, Wang Y, Chang D, Fu H, Cai H, Zhang Y, Hou CR, Xu Y, Zhou D, Ge J. Zhang X, et al. JACC Asia. 2022 Sep 6;2(5):547-556. doi: 10.1016/j.jacasi.2022.04.009. eCollection 2022 Oct. JACC Asia. 2022. PMID: 36518725 Free PMC article.

10

Acute peripheral pulmonary embolism attributed to autoimmune haemolytic anaemia: a case report.

Xu J, Wang L, Chen F. Xu J, et al. BMC Cardiovasc Disord. 2020 Mar 4;20(1):106. doi: 10.1186/s12872-020-01401-8. BMC Cardiovasc Disord. 2020. PMID: 32131747 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters